SAS-B approvals exceed 20,000 for third successive month by Steve Jones August 6, 2026August 6, 2026 Prescriptions through the Special Access Scheme hit the second highest of the year in July with […]
SAS-B deep dive: June hits new record for TGA approvals as pastilles surge and oil declines by Steve Jones July 8, 2026July 8, 2026
May SAS-B approvals hit 2026 high as Victoria extends prescribing lead by Adam Sheldon June 3, 2026June 4, 2026
April SAS-B figures: pastilles hit nearly one-third of approvals by Adam Sheldon May 7, 2026May 7, 2026
Bioxyne lifts FY26 guidance after margin growth in strong first half by Steve Jones February 26, 2026February 26, 2026
TGA offers first clues to where industry can expect to face regulatory reform by Steve Jones February 23, 2026February 25, 2026
Pastilles surge again as SAS-B data shows strong start to 2026 by Steve Jones February 2, 2026February 3, 2026
SAS-B deep dive: approvals climb 26% in 2025 as flower overtakes oil and pastilles surge by Adam Sheldon January 13, 2026January 14, 2026
